UH Researcher Uses Immunotherapy Expertise to Fight Cancer and Parkinson’s Disease
Weiyi Peng awarded $1M and $250,000 grants to apply immune therapy research.
COVID-19 Effort: HP Donates D300e BioPrinter to Center for Nuclear Receptors and Cell Signaling
Sanghyuk Chung to use in drug screening development.
Showing Promise: Fighting COVID-19
Zhang explores vaccine candidates.
Contraceptive Drug Shows Promise for Preventing and Regressing Cervical Cancer
Findings suggest a new affordable non-invasive approach.
The Role of a Single Molecule in Obesity
Molecule mimics high-fat diet-induced signaling.
Finding Therapeutic Targets to Prevent Atherosclerosis
UH biologist discovers protein partnership that protects blood vessels.
A Focus on Disease: The Center for Nuclear Receptors and Cell Signaling
Center funded by 18 active grants, with a total award amount of $8.7 million.
Researchers Link Defects in a Nuclear Receptor in the Brain to Autism Spectrum Disorders
UH researchers advance understanding of autism.
All News Releases